The Clinical Use of Dried Fibrinogen (Human) and the Risk of Transmitting Hepatitis by Its Administration
- 6 May 1966
- journal article
- research article
- Published by Wiley in Transfusion
- Vol. 6 (3) , 234-246
- https://doi.org/10.1111/j.1537-2995.1966.tb04730.x
Abstract
No abstract availableThis publication has 28 references indexed in Scilit:
- Immunization Against Serum Hepatitis from Blood TransfusionAnnals of Surgery, 1964
- Serum HepatitisJAMA, 1963
- PREVENTION OF HIGH FATALITY RATE IN SERUM HEPATITISPublished by American Medical Association (AMA) ,1963
- FIBRINOGEN-TRANSMITTED HEPATITISThe Lancet, 1963
- Serum Hepatitis from Transfusions of BloodJAMA, 1962
- ETIOLOGY OF FIBRINOPENIA: FIBRINATION DEFIBRINATION*Annals of the New York Academy of Sciences, 1959
- Methods for the PreDaration and Ultraviolet Irradiation of HLman Fibrino-g en for Intravenous Use**Division of Laboratories, Michigan Department of Health, Lansing, Mich.Journal of the American Pharmaceutical Association (Scientific ed.), 1957
- Dried Fraction I for Clinical Use from Smallest Plasma Pools, Sterile without FiltrationVox Sanguinis, 1957
- AN EVALUATION OF IMMUNE SERUM GLOBULIN AS A PROPHYLACTIC AGENT AGAINST HOMOLOGOUS SERUM HEPATITISThe Lancet Healthy Longevity, 1947
- Preparation and Properties of Serum and Plasma Proteins. IV. A System for the Separation into Fractions of the Protein and Lipoprotein Components of Biological Tissues and Fluids1a,b,c,dJournal of the American Chemical Society, 1946